Fabtech Technologies Cleanrooms Ltd
Incorporated in 2015, Fabtech Technologies Cleanrooms Limited is a global company specializing in turnkey engineering solutions for the pharmaceutical, biotech, and healthcare sectors.[1]
- Market Cap ₹ 342 Cr.
- Current Price ₹ 278
- High / Low ₹ 470 / 162
- Stock P/E 28.6
- Book Value ₹ 77.2
- Dividend Yield 0.73 %
- ROCE 21.2 %
- ROE 18.1 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 27.0% CAGR over last 5 years
Cons
- The company has delivered a poor sales growth of 10.9% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Industrials Capital Goods Industrial Manufacturing Industrial Products
Part of BSE SME IPO
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| 89 | 70 | 114 | 125 | 97 | 150 | 164 | |
| 83 | 69 | 107 | 112 | 89 | 134 | 151 | |
| Operating Profit | 6 | 1 | 6 | 13 | 8 | 16 | 14 |
| OPM % | 7% | 2% | 5% | 10% | 9% | 11% | 8% |
| 1 | 0 | 0 | 0 | 1 | 1 | 2 | |
| Interest | 1 | 0 | 1 | 1 | 1 | 1 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 0 | 1 | 1 |
| Profit before tax | 6 | 1 | 5 | 12 | 7 | 16 | 14 |
| Tax % | 28% | -42% | 29% | 31% | 27% | 24% | |
| 4 | 1 | 4 | 8 | 6 | 13 | 12 | |
| EPS in Rs | 1,333.33 | 250.00 | 12.92 | 28.57 | 19.99 | 10.80 | 9.70 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 19% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 11% |
| 3 Years: | 10% |
| TTM: | 37% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 27% |
| 3 Years: | 54% |
| TTM: | 15% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 16% |
| Last Year: | 18% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.03 | 0.03 | 3 | 3 | 3 | 12 | 12 |
| Reserves | 31 | 32 | 35 | 43 | 49 | 82 | 83 |
| 10 | 7 | 8 | 6 | 6 | 1 | 10 | |
| 26 | 30 | 36 | 29 | 32 | 28 | 39 | |
| Total Liabilities | 67 | 69 | 82 | 81 | 89 | 124 | 144 |
| 4 | 5 | 4 | 4 | 5 | 4 | 10 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 1 | 27 | 10 |
| 63 | 64 | 77 | 76 | 83 | 93 | 124 | |
| Total Assets | 67 | 69 | 82 | 81 | 89 | 124 | 144 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| -9 | 4 | 3 | 8 | 3 | 3 | |
| 2 | -1 | -4 | -3 | -2 | -26 | |
| 7 | -3 | 1 | -4 | -1 | 24 | |
| Net Cash Flow | 1 | -0 | -0 | 1 | 0 | 1 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 181 | 221 | 165 | 144 | 193 | 129 |
| Inventory Days | 63 | 95 | 63 | 57 | 88 | 67 |
| Days Payable | 114 | 146 | 105 | 82 | 122 | 74 |
| Cash Conversion Cycle | 130 | 170 | 123 | 119 | 160 | 122 |
| Working Capital Days | 112 | 144 | 92 | 95 | 139 | 124 |
| ROCE % | 2% | 14% | 26% | 16% | 21% |
Documents
Announcements
-
Outcome Of The Analyst / Investor Meeting Held On December 22, 2025
22 Dec - Dec 22, 2025 virtual group analyst/investor meeting with multiple institutional investors; no UPSI discussed.
-
Intimation Of Receipt Of Purchase Order
19 Dec - Received Rs.330,006,870 purchase order from leading solar PV manufacturer; execution by April 30, 2026.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
17 Dec - Virtual analyst/investor meeting on Dec 22, 2025 at 04:00 PM IST; no UPSI to be shared.
-
Announcement under Regulation 30 (LODR)-Acquisition
17 Dec - Board approved 100% UAE subsidiary Fabtech Technologies Cleanrooms-FZE, authorised capital AED100,000; incorporation pending.
-
Revised Outcome Of The Board Meeting Held On December 17, 2025
17 Dec - Board approved UAE wholly-owned subsidiary Fabtech Technologies Cleanrooms-FZE; authorised capital AED100,000; Dec 17, 2025. ","checklist":["Review announcement to identify corporate action and specifics","Assess regulatory approvals, amounts, …
Annual reports
Concalls
-
Nov 2025Transcript PPT
-
Jun 2025TranscriptPPT
-
Mar 2025TranscriptAI SummaryPPT
-
Feb 2025TranscriptAI SummaryPPT
Business Overview[1]
Fabtech Technologies Cleanrooms specializes in manufacturing and providing end-to-end solutions for pre-engineered and pre-fabricated modular panels and doors for cleanrooms. These cleanrooms are used in pharmaceutical, healthcare, and biotech sectors and adhere to global regulatory standards like ISO and FDA. The company offers services including design, engineering, manufacturing, quality assurance, installation, and validation.